Bottle cap
Latest Eli Lilly and Company Patents:
- URI agonist/vasodilator
- ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY-DRUG CONJUGATES AND ANTI-VEGFR-2 ANTIBODIES
- Dose regimens for use of LY3154207 in the treatment of dopaminergic CNS disorders
- Antibodies that bind human and mouse INSL5 and encoding nucleic acids thereof
- Process for preparing a GIP/GLP1 dual agonist
Description
FIG. 1 is a top plan view of a bottle cap embodying my new design;
FIG. 2 is an elevational view, the opposite side being the same in appearance; and
FIG. 3 is an elevational view looking from the right of FIG. 2, the opposite side being the same in appearance.
The broken lines showing a bottle are for the purpose of illustrating environmental use only.
Referenced Cited
U.S. Patent Documents
| D87342 | July 1932 | Guerlain |
| D93068 | August 1934 | Westlake |
| D93070 | August 1934 | Westlake |
| D98040 | December 1935 | Lewis |
| D116214 | August 1939 | Bergaud |
| D155358 | September 1949 | Paulinetz |
| D270138 | August 16, 1983 | Rosen |
Patent History
Patent number: D275838
Type: Grant
Filed: Jan 21, 1982
Date of Patent: Oct 9, 1984
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventor: Marc A. Rosen (New York, NY)
Primary Examiner: Robert C. Spangler
Attorneys: Houston L. Swenson, Arthur R. Whale
Application Number: 6/341,397
Type: Grant
Filed: Jan 21, 1982
Date of Patent: Oct 9, 1984
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventor: Marc A. Rosen (New York, NY)
Primary Examiner: Robert C. Spangler
Attorneys: Houston L. Swenson, Arthur R. Whale
Application Number: 6/341,397
Classifications
Current U.S. Class:
D/9435
